Table of Contents
Member Developments - August 2026
Helix
Helix has been driving innovation on multiple fronts lately, extending its genomic medicine model to new health systems while opening fresh ground in AI-powered research. Nebraska Medicine and Memorial Hermann Health System both launched Helix Genomic Advantage to integrate clinical-grade genomic insights into workforce care, following St. Luke's earlier rollout. The company also introduced a GenoSphere MCP connector in Claude, giving approved researchers access to more than 500,000 linked clinico-genomic records, and struck a multi-year agreement giving AstraZeneca access to its growing GenoSphere cohorts to support drug discovery. Read the full articles here, here, and here.
BD
BD launched the BD® CentroVena One™ Insertion System, a first‑of‑its‑kind approach to central line insertion designed to simplify placement and reduce complexity while supporting health system priorities around patient safety, clinical workflow and operational performance. Read the full article here.
Redaptive
Deferred maintenance used to be a facilities problem. In 2026, it's a credit committee problem. Redaptive CFO John Sullivan breaks down why rising energy costs, aging hospital infrastructure, and razor-thin margins are converging to put facility condition on the balance sheet and why the two default responses (deferring the work, or waiting for the next bond issuance) both make the problem worse. John outlines a third option that funds modernization on the infrastructure's timeline instead of the budget cycle, without touching debt capacity. Read the full article here.
McDermott Will & Schulte
Health system executives are reimagining how they grow, partner, and compete. For many organizations, full integration or acquisition is no longer the preferred or available path. Instead, leaders are turning to a broader range of partnership models while accelerating investment in outpatient and ambulatory infrastructure. McDermott Will & Schulte examines the evolving partnership landscape, outlines the strategic imperatives driving ambulatory growth, and explores how physician alignment, payor strategy, and AI adoption are reshaping what it means to build a durable, high-performing health system. Read the full article here.
Fidelity
This article from Fidelity examines how physicians are navigating their careers today, focusing on professional satisfaction, financial wellbeing, and long-term planning. It highlights the growing pressures doctors face like burnout, workload, and changing work structures while showing that many are still forward-looking and motivated to build more balanced, sustainable careers. The article covers insights into what’s driving physician stress, what influences their career decisions, and how employers and financial support systems can better meet their evolving needs. Read the full article here.
Surgical Directions
Hospitals are navigating unprecedented operational and financial pressure driven by labor shortages, inflationary supply costs, reimbursement compression, and rising patient acuity. For Chief Operating Officers (COOs), perioperative and surgical services represent both the greatest operational complexity and the greatest opportunity to improve financial performance. Surgical services often represent up to 70 percent of hospital revenue while consuming a significant portion of labor and capital resources. When operations are misaligned, hospitals experience lost capacity, staff burnout, physician dissatisfaction, and margin erosion. Conversely, with operational optimization, hospitals unlock sustainable financial improvement while strengthening quality, access, and workforce stability. This guide from Surgical Directions provides COOs with a comprehensive, evidence-based framework to drive operational improvements that directly enhance financial performance. Read the whitepaper here.
Paradigm Health
Paradigm Health is collaborating with the U.S. Food and Drug Administration (FDA) as the sole technology and execution partner in the FDA's Real-Time Clinical Trials (RTCT) proof-of-concept trials, which are part of an administration-wide effort to expedite clinical development in the United States. The RTCT initiative is exploring how electronic health records and other source data collected at doctor visits can support more efficient evidence generation in clinical trials. By leveraging clinical data captured during the delivery of care and analyzing aggregated data to identify pre-determined signals, the initiative aims to reduce the operational burden of research teams and regulators, accelerate study execution, and improve the integration of research into everyday healthcare. Paradigm Health's participation reflects its broader mission to embed clinical research within health systems across diverse geographies, enabling providers to identify eligible patients, streamline trial workflows, and expand access to research opportunities without disrupting clinical care. The initiative represents another step toward a future where clinical research becomes a care option for more patients, everywhere. Learn more here.
uPerform
With the help of uPerform's enablement infrastructure, Emplify Health's Epic consolidation delivered results most health systems only aim for: 66% faster nurse onboarding and an 890% surge in user engagement across a newly merged organization. See how they did it here.
RevSpring
Emory Healthcare's access and revenue cycle leaders joined RevSpring to discuss what it takes to move patients from initial search to completed, affordable care. Emory shared how they redesigned scheduling infrastructure to improve provider matching and minimize patient friction across digital and phone channels. Their cross-functional partnership to address out-of-network scheduling errors produced a nearly 70% reduction within three months through coordinated alerts and staff scripting. The session also covered how pre-service payment plans, flexible collection options, and proactive cost communication help retain patients who might otherwise defer care due to affordability concerns. Watch the full recording to hear how Emory is operationalizing these changes across the enterprise.
Inflammatix
In a recent virtual session, University of South Alabama (USA) Health shared how acute infection disposition is an underaddressed lever for hospital throughput, capacity, and financial performance. The session explored limitations of traditional ED diagnostics and how USA Health's emergency medicine team used host immune response testing created by Inflammatix to gain earlier severity and etiology data at triage. In a 124-patient cohort, the diagnostic changed 44 percent of disposition decisions, reduced admissions by 8 percent, lowered bounce-backs by 17 percent, and generated $687,000 in combined financial impact. The conversation also addressed workflow integration, clinician adoption, and SEP-1 compliance. Watch the full recording for case studies and implementation guidance.
Curvo
Recent surveys conducted by Curvo reveal widespread challenges with rebate management across healthcare supply chains, with many organizations lacking confidence that they are capturing all rebate dollars owed. In this executive Q&A, Curvo's Joe Jackson, Chief Customer Officer, and Lauren Campbell, SVP of Product Development, discuss what those survey findings reveal about rebate visibility, accuracy and manual processes, and how Curvo is rethinking rebate management. Read the full article here.
Arcadia
Arcadia released its latest survey of 281 healthcare leaders, revealing strong confidence in AI's potential to transform healthcare, but only 14% have fully integrated AI insights into decision-making. The findings explore what's holding organizations back and what it will take to translate AI investments into measurable outcomes. Read the press release here.
Clarium
In partnership with Clarium, Yale New Haven Health (YNHHS) identified a multimillion-dollar savings opportunity by eliminating the overpurchasing of surgical supplies used in the operating room. YNHHS and Clarium worked in close partnership to co-build several flagship Clarium Platform capabilities. To ensure Clarium solved pain points for users and stakeholders across the system, YNHHS included partners from supply chain, value analysis, and clinical teams throughout the development process. Together, YNHHS and Clarium identified $3.1M in supply waste on preference cards, with $1.3M in savings already realized to date. Read more on this case study here.
Birdeye
Birdeye View is Birdeye's annual virtual conference for enterprise leaders—including healthcare marketers and digital executives—exploring how AI is transforming customer experience, marketing, and operations. The event features thought leaders, customer stories, and the latest AI innovations from across industries. On September 9–10, 2026, Birdeye View 2026: Agents at Work will feature more than 20 sessions with practical AI strategies, real-world success stories, and an exclusive look at Birdeye's newest AI agent innovations to help organizations drive growth, improve efficiency, and enhance customer engagement. Read more about the event here.
Amsive Health
Lower acquisition costs can make healthcare campaigns look efficient, but cheaper conversions don't always translate into meaningful growth. Amsive Health’s latest blog challenges the reflex to optimize around the lowest CPA (cost per acquisition) and shows how that mindset can steer budget toward short-term volume while pulling focus from the audiences and service lines that create lasting value. Gary Stubblefield, SVP, Healthcare Strategy & Innovation, reframes efficiency as a strategic discipline, not a channel-level metric. He explores how healthcare marketers can use audience intelligence to decide where investment should go, define what each channel is meant to accomplish across the patient journey, and evaluate performance based on business value rather than conversion counts alone. For healthcare teams navigating tighter budgets, rising expectations, and a more complex media environment, the blog offers a smarter way to connect marketing decisions to sustainable growth. Read the full article here.
McKesson
McKesson has launched its Specialty & Infusion Assessment, a complimentary digital tool that helps health systems understand where they stand today and identify clear opportunities for growth in an increasingly complex specialty pharmacy and infusion landscape. As organizations navigate rising specialty drug spend, patient access challenges, operational complexity, and mounting pressure to grow sustainably, the assessment connects where a health system is today to the actions that can move it forward. In just 10 questions, leaders evaluate their current maturity across strategy, analytics, patient drug access, operational coordination, and growth readiness—then receive immediate, personalized results placing them in a Plan, Grow, or Mature stage, along with recommended next steps. Because growth starts with knowing where you are today, the assessment gives health systems a clear path to achieve more for the advancement of patient health. Take the assessment here.
Aledade
Aledade has released a new resource breaking down the Centers for Medicare & Medicaid Services (CMS) annual physician fee schedule (PFS) updates. Understanding the Medicare physician fee schedule is essential for clinicians managing Medicare payments and care team reimbursements while maintaining a focus on patient outcomes. Adopting value-based care models empowers primary care organizations to maximize these reimbursement rates and earn shared savings. Read the full article here.
Innovaccer
Gartner has published its first-ever Magic Quadrant for Healthcare Provider Industry Cloud Platforms, and named Innovaccer a Leader in this inaugural evaluation.
The new Magic Quadrant signals that healthcare AI platforms have matured into a formally evaluated market, and Innovaccer's Leader placement reflects more than a decade of work building a unified data layer that connects disparate EHR environments, automates administrative workflows, and powers clinical and financial decision-making at scale.
For health system leaders evaluating AI infrastructure, this offers an independent reference point as the market consolidates.